Leaderboard

En | De
No articles selected!     View Cart  
You are here: Oncology » Urologic Neoplasms 05. January 2026
Search
medline.ch
Urologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 8749  Previews Next
   
   Articles 1 - 20 / 174961  
   
Robot-assisted versus open radical cystectomy with extracorporeal urinary diversion for bladder cancer: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials with subgroup analyses by orthotopic neobladder utilisation.
J Robot Surg
Orakzai FK, Mirza W, Khan ME, Iqbal H, Khan A, Moeen-Ud-Din MB, Iqbal MW, Khan HM.
PMID: 41486201 [PubMed - in process]


Stereotactic Radiation for Systemic Therapy-naïve Oligometastatic Kidney Cancer: Final Results of a Phase 2b Trial.
Eur Urol Oncol
Hannan R, Assadi R, Christie A, Puliyadi V, Garant A, Hammers H, Arafat W, Courtney K, Sher D, Ahn C, Cole S, Brugarolas J, Timmerman R.
PMID: 41486044 [PubMed - as supplied by publisher]


Results of the Randomized Phase 3 AFU-GETUG-20 Trial Evaluating Adjuvant Leuprorelin Acetate After Radical Prostatectomy in Men with High-risk Localized Prostate Cancer.
Eur Urol Oncol
Rozet F, Ruffion A, Lemercier P, Soulié M, Robert G, Walz J, De La Taille A, Salomon L, Pfister C, Mathieu R, Vincendeau S, Descazaud A, Latorzeff I, Brureau L, Colombel M, Rouprêt M, Roca L, Pérez C, Marion S, Barret E, Cathelineau X, Fizazi K, Culine S, GETUG-20 Investigators.
PMID: 41486043 [PubMed - as supplied by publisher]


Re: Paramananthan Mariappan, Jasmin Hart-Brooke, Rebecca Sparks, Tanya Lord-McKenzie. Bladder EpiCheck Triggered Photodynamic Diagnosis Biopsies Detect High-grade Bladder Cancer Recurrences Missed by White Light Cystoscopy. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2025.11.007.
Eur Urol Oncol
May M, Wolff I, Brookman-May S, Burger M.
PMID: 41486041 [PubMed - as supplied by publisher]


Ultrahypofractionated Versus Conventionally Fractionated Whole-pelvis Radiotherapy in Prostate Cancer: A Randomized Clinical Trial.
Eur Urol Oncol
Mendez LC, Crook J, Martell K, Velker V, Ahmad B, Lock M, Dhar A, Halperin R, Schaly B, Hoover DA, Warner A, Bauman GS, D'Souza DP.
PMID: 41486040 [PubMed - as supplied by publisher]


Patient selection for triplet therapy with darolutamide in metastatic castration-sensitive prostate cancer and patterns of administration: a Spanish multicenter study.
Clin Transl Oncol
Alonso-Gordoa T, Fernández-Calvo O, García-Carbonero I, Álvarez-Rodríguez S, Sánchez-Escribano R, Anguera G, González-Del-Alba A, Gallardo E, Cacho D, Vidal N, Pinto Á, Perezagua C, Zafra-Poves M, Cassinello J, Rodriguez-Vida A, López-Campos F, Vázquez-Estévez S.
PMID: 41485187 [PubMed - as supplied by publisher]


Analysis of the care needs of family caregivers of patients with bladder cancer undergoing urostomy: a cross-sectional study.
Sci Rep
Guo C, Zhou Y, Liu X, Gao K, Xu H, Li Y, Han X.
PMID: 41484424 [PubMed - as supplied by publisher]


Artificial intelligence in diagnostic, prognostic, and predictive genomic biomarkers for prostate cancer: Ready for prime time?
Urol Oncol
Bazarkin A, Taratkin M, Vovdenko S, Androsov A, Balashova M, Morozov A, Itskevich A, Laukhtina E, Bezrukov E, Singla N, Rapoport L, Shpot E, Glybochko P.
PMID: 41483979 [PubMed - as supplied by publisher]


Robotic-assisted radical prostatectomy in patients 80+ years: a multi-centre experience.
J Robot Surg
Flegar L, Shi W, Pan HYC, Santiago MA, Thomas BC, Lawrentschuk N, Moon D, Dundee P.
PMID: 41483419 [PubMed - indexed for MEDLINE]


Correction: LDB2 is a novel diagnostic and prognostic biomarker and inhibits bladder cancer metastasis by activating p38 MAPK/ERK1/2/JNK signaling pathway.
Clin Exp Med
Li Y, Zhao B, Gao W, Wu Y, Tian T, Zhao S, Zhang J, Li R, He S, Gong Y, Ma J, Li X.
PMID: 41483418 [PubMed - in process]


Exploring the use of preoperative MRI for assessing the anatomical location of positive surgical margin at robot-assisted radical prostatectomy (RARP).
World J Urol
van der Graaf SH, Boellaard TN, Vis AN, Sweere V, Veerman H, Wit EMK, Roeleveld TA, Nieuwenhuijzen JA, van der Poel HG, van Leeuwen PJ.
PMID: 41483404 [PubMed - indexed for MEDLINE]


Influence of diabetes mellitus and anti-diabetic drugs on pathophysiology and prognosis for primary prostate cancer.
Int Urol Nephrol
Kazachok M, , Zapa, Piecha T, Radziszewski P, Zapa.
PMID: 41483135 [PubMed - as supplied by publisher]


Sleep Duration and Prostate Cancer Risk in the Southern Community Cohort Study.
Cancer Med
Anukam DC, Nianogo RA, Arah OA, Boutros PC, Rao J, Fowke JH, Zhang ZF.
PMID: 41482760 [PubMed - indexed for MEDLINE]


Comparative Analysis of Immune-based Combination Therapy as First-line Treatment for Advanced Renal Cell Carcinoma.
In Vivo
Mukae Y, Ohba K, Nakanishi H, Oki M, Kawada K, Matsuda T, Mitsunari K, Matsuo T, Mochizuki Y, Imamura R.
PMID: 41482401 [PubMed - indexed for MEDLINE]


Serum Zinc Levels and Skin-related Adverse Events During Systemic Therapy for Renal Cell Carcinoma.
In Vivo
Saito S, Sazuka T, Sato H, Watanabe Y, Yokochi F, Toma K, Onoda Y, Nagaoka K, Pae S, Sato K, Ando K, Yamada Y, Imamura Y, Sakamoto S.
PMID: 41482397 [PubMed - indexed for MEDLINE]


Identification of serum protein biomarkers for clear cell renal cell carcinoma using patient-derived xenografts.
J Clin Invest
Zhang D, Chiu CL, Garcia Marques FJ, Bermudez A, Hoerner CR, Hadi N, Wang E, Metzner TJ, Trabanino L, Leppert JT, Zhao H, Tibshirani R, Fan AC, Pitteri SJ, Brooks JD.
PMID: 41480764 [PubMed - indexed for MEDLINE]


Prognostic Significance of High-Risk versus Very High-Risk Classification in Non-Surgically Managed Prostate Cancer: A Retrospective Cohort Study.
Cancer Manag Res
A, Demir MS.
PMID: 41480518 [PubMed]


Advances in prostate cancer treatment with moderate and ultra-hypofractionated radiotherapy.
World J Clin Oncol
Meng LL, Di YP, Ma L, Qu BL.
PMID: 41480171 [PubMed]


Microfluidics and molecular diagnostics in renal cell carcinoma: advances, challenges, and future directions.
Front Oncol
Abu-Dawas SB, Alwadi AY, Farahat YH, Abu-Dawas RB, Quraiba LN, Abu-Omar RA, AlKattan K, Khan MI, Yaqinuddin A.
PMID: 41479787 [PubMed]


Deep learning-based dose prediction for prostate cancer with empty bladder protocol: a framework for efficient and personalized radiotherapy planning.
Front Oncol
Choi B, Shrestha DK, Attia A, Stish BJ, Leenstra J, Rwigema JC, Ma J, Lee SU, Jeong JH, Kim J, Kim J, Beltran C, Park JC.
PMID: 41479786 [PubMed]


   
   Articles 1 - 20 / 174961    Page 1 of 8749  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1